CD19 ANTIGEN LOSS

This adverse event was reported 16 times

CD19 ANTIGEN LOSS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAFASITAMAB-CXIX 2 0.0022
1 ETOPOSIDE PHOSPHATE 1 0.0006
2 BLINATUMOMAB 5 0.0005
3 GLOFITAMAB 1 0.0004
4 AXICABTAGENE CILOLEUCEL 1 0.0001
5 RIFAMPIN 1 0.0001
6 BENDAMUSTINE HCL 1 0.0001
7 TERIFLUNOMIDE 2 0.0000
8 VINCRISTINE SULFATE 1 0.0000
9 BELIMUMAB 1 0.0000
See all drugs enriched for association with CD19 ANTIGEN LOSS